292 related articles for article (PubMed ID: 31468350)
21. INI-1 (SMARCB1)-Deficient Undifferentiated Sinonasal Carcinoma: Novel Paradigm of Molecular Testing in the Diagnosis and Management of Sinonasal Malignancies.
Shaverdashvili K; Azimi-Nekoo E; Cohen P; Akbar N; Ow TJ; Halmos B; Castellucci E
Oncologist; 2020 Sep; 25(9):738-744. PubMed ID: 32337786
[TBL] [Abstract][Full Text] [Related]
22. Case Report: SMARCB1 (INI-1)-Deficient Carcinoma of the Nasal Cavity with Pure Yolk Sac Tumor Differentiation and Elevated Serum AFP Levels.
Li CY; Han YM; Xu K; Wu SY; Lin XY; Cao HY
Onco Targets Ther; 2021; 14():2227-2233. PubMed ID: 33824593
[TBL] [Abstract][Full Text] [Related]
23. SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: A clinicopathological, immunohistochemical and molecular genetic study of a recently described entity.
Laco J; Chmelařová M; Vošmiková H; Sieglová K; Bubancová I; Dundr P; Němejcová K; Michálek J; Čelakovský P; Mottl R; Sirák I; Vošmik M; Ryška A
Pathol Res Pract; 2017 Feb; 213(2):133-142. PubMed ID: 28069272
[TBL] [Abstract][Full Text] [Related]
24. Sinonasal undifferentiated carcinoma: clinicopathological spectrums and diagnosis reappraisal.
Vaziri Fard E; Zhang S; Cai Z; Ding J; Sun Q; Saluja K; Zhu H
Hum Pathol; 2019 Jul; 89():62-70. PubMed ID: 31054892
[TBL] [Abstract][Full Text] [Related]
25. Genetic basis of SMARCB1 protein loss in 22 sinonasal carcinomas.
Dogan S; Cotzia P; Ptashkin RN; Nanjangud GJ; Xu B; Momeni Boroujeni A; Cohen MA; Pfister DG; Prasad ML; Antonescu CR; Chen Y; Gounder MM
Hum Pathol; 2020 Oct; 104():105-116. PubMed ID: 32818509
[TBL] [Abstract][Full Text] [Related]
26. SWI/SNF-deficient Sinonasal Carcinomas.
Agaimy A
Adv Anat Pathol; 2023 Mar; 30(2):95-103. PubMed ID: 36580412
[TBL] [Abstract][Full Text] [Related]
27. Endometrial tumors with yolk sac tumor-like morphologic patterns or immunophenotypes: an expanded appraisal.
Fadare O; Shaker N; Alghamdi A; Ganesan R; Hanley KZ; Hoang LN; Hecht JL; Ip PP; Shaker N; Roma AA; Parkash V; Abubakr H
Mod Pathol; 2019 Dec; 32(12):1847-1860. PubMed ID: 31375771
[TBL] [Abstract][Full Text] [Related]
28. Newly Described Tumor Entities in Sinonasal Tract Pathology.
Bishop JA
Head Neck Pathol; 2016 Mar; 10(1):23-31. PubMed ID: 26830406
[TBL] [Abstract][Full Text] [Related]
29. High-level expression of divergent endodermal lineage markers in gonadal and extra-gonadal yolk sac tumors.
Shojaei H; Hong H; Redline RW
Mod Pathol; 2016 Oct; 29(10):1278-88. PubMed ID: 27443515
[TBL] [Abstract][Full Text] [Related]
30. Among sinonasal tumors, CDX-2 immunoexpression is not restricted to intestinal-type adenocarcinomas.
Tilson MP; Gallia GL; Bishop JA
Head Neck Pathol; 2014 Mar; 8(1):59-65. PubMed ID: 23846317
[TBL] [Abstract][Full Text] [Related]
31. SMARCA4-deficient Sinonasal Carcinoma: A Series of 10 Cases Expanding the Genetic Spectrum of SWI/SNF-driven Sinonasal Malignancies.
Agaimy A; Jain D; Uddin N; Rooper LM; Bishop JA
Am J Surg Pathol; 2020 May; 44(5):703-710. PubMed ID: 31934917
[TBL] [Abstract][Full Text] [Related]
32. Yolk sac tumor of postpubertal-type does not exhibit immunohistochemical loss of SMARCB1/INI1 and SMARCA4/BRG1…but choriocarcinoma?
Ricci C; Ambrosi F; Franceschini T; Giunchi F; Franchini E; Massari F; Mollica V; Bianchi FM; Colecchia M; Acosta AM; Fiorentino M
Pathol Res Pract; 2023 Jan; 241():154269. PubMed ID: 36502737
[TBL] [Abstract][Full Text] [Related]
33. [Clinicopathological characteristics of SMARCB1(INI1)-deficient sinonasal carcinoma].
Wang JY; Bai YP; Xing L; Piao YS; He XJ; Yue CL; Zhao XL; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2021 Nov; 50(11):1240-1245. PubMed ID: 34719161
[No Abstract] [Full Text] [Related]
34. SMARCB1/INI1 Deficient Sino-Nasal Carcinoma: Extending the Histomorphological Features.
Ayyanar P; Mishra P; Preetam C; Adhya AK
Head Neck Pathol; 2021 Jun; 15(2):555-565. PubMed ID: 33141418
[TBL] [Abstract][Full Text] [Related]
35. SMARCB1-Deficient Sinonasal Carcinoma: Case Report and Review of the Literature.
AlMadan NM; AlEssa EA; AlGhamdi DA
Am J Case Rep; 2023 May; 24():e939244. PubMed ID: 37198880
[TBL] [Abstract][Full Text] [Related]
36. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma.
Kennedy MT; Jordan RC; Berean KW; Perez-Ordoñez B
J Clin Pathol; 2004 Sep; 57(9):932-7. PubMed ID: 15333652
[TBL] [Abstract][Full Text] [Related]
37. ETV6 Gene Rearrangements Characterize a Morphologically Distinct Subset of Sinonasal Low-grade Non-intestinal-type Adenocarcinoma: A Novel Translocation-associated Carcinoma Restricted to the Sinonasal Tract.
Andreasen S; Skálová A; Agaimy A; Bishop JA; Laco J; Leivo I; Franchi A; Larsen SR; Erentaite D; Ulhøi BP; von Buchwald C; Melchior LC; Michal M; Kiss K
Am J Surg Pathol; 2017 Nov; 41(11):1552-1560. PubMed ID: 28719468
[TBL] [Abstract][Full Text] [Related]
38. INI1 (SMARCB1)-Deficient Sinonasal Carcinoma: A Clinicopathologic Report of 2 Cases.
Wasserman JK; Dickson BC; Perez-Ordonez B; de Almeida JR; Irish JC; Weinreb I
Head Neck Pathol; 2017 Jun; 11(2):256-261. PubMed ID: 27644951
[TBL] [Abstract][Full Text] [Related]
39. Recently described neoplasms of the sinonasal tract.
Bishop JA
Semin Diagn Pathol; 2016 Mar; 33(2):62-70. PubMed ID: 26776744
[TBL] [Abstract][Full Text] [Related]
40. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
Pawel BR
Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]